WallStreetZenWallStreetZen

NYSE: ATR
Aptargroup Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ATR past earnings growth

How has ATR's earnings growth performed historically?
Company
34.08%
Industry
27.71%
Market
72.61%
ATR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ATR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ATR's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ATR past revenue growth

How has ATR's revenue growth performed historically?
Company
6.16%
Industry
7.53%
Market
17.55%
ATR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ATR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ATR's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ATR earnings and revenue history

Current Revenue
$3.5B
Current Earnings
$312.8M
Current Profit Margin
8.8%
ATR's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ATR Return on Equity

Current Company
13.9%
Current Industry
4.9%
Current Market
28.2%
ATR's Return on Equity (13.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ATR announces earnings.

ATR Return on Assets

Current Company
7.1%
Current Industry
4.7%
ATR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ATR Return on Capital Employed

Current Company
13.78%
Current Industry
7%
ATR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ATR vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ATR$3.54B$700.23M$312.83M+4.77%+8.47%
RGEN$638.76M$134.17M$41.58M+26.91%+14.57%
TFX$2.97B$759.97M$356.33M+3.97%+11.54%
STVN$1.18B$325.43M$158.29M+18.93%+35.74%
XRAY$3.97B$249.00M-$132.00M-0.11%N/A
View Top Medical Stocks

ATR earnings dates

Next earnings date
May 1, 2024

Aptargroup Earnings & Revenue FAQ

What were ATR's earnings last quarter?

On Invalid Date, Aptargroup (NYSE: ATR) reported Q1 2024 earnings per share (EPS) of $1.26, up 50% year over year. Total Aptargroup earnings for the quarter were $83.10 million. In the same quarter last year, Aptargroup's earnings per share (EPS) was $0.84.

If you're new to stock investing, here's how to buy Aptargroup stock.

What was ATR's earnings growth in the past year?

As of Q2 2024, Aptargroup's earnings has grown 34.08% year over year. This is 6.38 percentage points higher than the US Medical Instruments & Supplies industry earnings growth rate of 27.71%. Aptargroup's earnings in the past year totalled $312.83 million.

What is ATR's earnings date?

Aptargroup's earnings date is Invalid Date. Add ATR to your watchlist to be reminded of ATR's next earnings announcement.

What was ATR's revenue last quarter?

On Invalid Date, Aptargroup (NYSE: ATR) reported Q1 2024 revenue of $915.45 million up 6.44% year over year. In the same quarter last year, Aptargroup's revenue was $860.07 million.

What was ATR's revenue growth in the past year?

As of Q2 2024, Aptargroup's revenue has grown 6.16% year over year. This is 1.37 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 7.53%. Aptargroup's revenue in the past year totalled $3.54 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.